The clinical and cost effectiveness of topotecan for ovarian cancer

Health Technology Assessment

Type:

Extended Research Article Our publication formats
Authors:

Forbes C, Shirran L, Bagnall A-M, Duffy S, ter Riet G.
Journal:

Health Technology Assessment
Issue:

Volume: 5, Issue: 28
Published:

September 2001
Citation:

Forbes C, Shirran L, Bagnall A-M, Duffy S, ter Riet G. The clinical and cost effectiveness of topotecan for ovarian cancer. Health Technol Assess 2001;5(28). https://doi.org/10.3310/hta5280
DOI:

https://doi.org/10.3310/hta5280